What Is Enclomiphene?
Enclomiphene is a selective estrogen receptor modulator (SERM) studied for how it influences the hypothalamic pituitary gonadal axis by reducing estrogen receptor signaling at the hypothalamus and pituitary. In research contexts, it is primarily explored for its ability to increase LH and FSH output, which can raise endogenous testosterone production in responsive models. It is often discussed as the trans isomer associated with a more stimulating endocrine profile compared with mixed clomiphene isomer products.
Mechanisms of Action
Antagonize estrogen receptors at the hypothalamus and pituitary
Reduce estrogen mediated negative feedback signaling
Increase GnRH pulsatility signaling upstream
Increase LH and FSH secretion
Support increased testicular testosterone production in responsive systems
Preserve intratesticular testosterone compared with exogenous testosterone models, depending on study design
Because it shifts feedback signaling rather than replacing testosterone directly, outcomes depend heavily on baseline physiology and HPTA integrity.
Benefits
Increased LH and FSH output in responsive subjects
Increased total testosterone and often free testosterone, depending on SHBG dynamics
Preservation of spermatogenesis related signals in contexts where exogenous testosterone would typically suppress it
Variable estrogen related symptom changes driven by aromatization as testosterone rises
Mood and libido changes that can vary substantially by baseline neuroendocrine state
Dosing
Strength | Dose |
|---|---|
Low | 6.25 mg every other day, or 12.5 mg twice per week |
Medium | 12.5 mg every other day, or 12.5 mg daily |
High | 25 mg daily |
Safety Profile
Side effects reported include:
• Headache and visual disturbance type signals in SERM sensitive individuals
• Mood variability, anxiety, or irritability in some models
• Libido fluctuations and sleep disruption in stimulation sensitive subjects
• Gastrointestinal discomfort
• Elevated estradiol in some cases secondary to increased testosterone conversion
• Rare but clinically significant SERM class risk signals discussed in literature include thromboembolic risk, typically treated as a conservative monitoring consideration in longer duration designs
Stacking
Post Cycle Therapy Stack
Enclomiphene
HCG
HMG
Glutathione
Fish Oil
Testosterone Boost Stack
Enclomiphene
DHEA
Pregnenolone
Hormonal Boost Stack
Enclomophine
CJC-1295 (No DAC) or Tesamorelin
Ipamorelin
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
